effects on rats of compounds related to acrylamide. Nine compounds (Table) , close chemical relations of acrylamide, were given to adult rats both in their diet and as repeated daily doses by mouth. Dose rates were such that with acrylamide acute poisoning and neuropathy would have resulted. Seven of the compounds were without effect. N-methylacrylamide and N-hydroxymethylacrylamide produced some neurotoxic effects in large doses. The presence of acrylamide as an impurity in the compound tested was not excluded.
The observation that rats given repeated doses of acrylamide (I) developed a peripheral neuropathy (Fullerton and Barnes, 1966) explained the unusual toxic effects of this compound that had been reported earlier by others (McCollister, Oyen, and Rowe, roused by the discovery of clinical peripheral neuropathy in men who were occupationally exposed to acrylamide under poor general hygienic conditions (Garland and Patterson, 1967) . In experiments (unpublished) carried out in 1963 in this laboratory, it was observed that N-hydroxymethylacrylamide (V), which was being used commercially, did not produce the same acute or chronic toxic effects on rats as acrylamide.
When the nature of the lesion produced by acrylamide had been established part of the initial studies of the mechanism involved included an examination of the effects of some closely related compounds. Because some of the compounds have an actual or potential industrial use, these findings are recorded and briefly discussed. Fassett (1963) N-Methylacrylamide (IV) and N,N-diethylacrylamide (VI), prepared according toKoton, Sokolova, Savritskaya, and Kiseleva (1958) , were colourless oils, ND23 1 4723 and 1P4666 respectively. Crotonamide (VIII) and senecioic acid amide (IX) were prepared from the acids by standard methods and had melting points of 1620 and 11 30 respectively.
Young adult albino rats of the Porton strain were used. Single oral doses were given in aqueous solutions. For long-term feeding the powders were added to MRC diet 41B in powder form and mixed with a Hobart mixer for 20 minutes.
The animals were weighed weekly and their gait and stance were observed when walking on a non-slippery surface including an ascent up a sloping wooden board. A good test for hind limb activity was to hold the rat by the tail in front of a sloping bar. When a normal rat grasps this with the front paws it then quickly finds it and grasps it with the hind feet. This reflex is lost early in peripheral neuropathies. The ability to maintain itself on a smooth bar is a measure of muscle strength and normal sensation in the paws.
Results
I Acrylamide Given as two doses of 100 mg/kg by mouth on successive days, this killed most rats within a few days, with signs of gross general weakness. Given in the diet at 400 ppm, signs of disability were evident within four weeks and were marked by eight weeks.
In the majority of the tests with the other compounds, a group of six male rats was given the compound in the diet at 400 ppm for 10 weeks and then at 800 ppm for a further three weeks. At the end of this period a succession of oral doses was given to four of the six rats leaving two as untreated controls. The details for each compound follow: II Sodium acrylate Ten weeks feeding at 400 ppm was followed by three weeks at 800 ppm and then four rats were given seven successive doses of 100 mg/kg over the next nine days. There were no adverse effects.
III Acrylonitrile
Six rats were given 15 successive doses of 30 mg/kg followed by seven doses of 50 mg/kg and then 13 doses of 75 mg/kg over a period of seven weeks. There were no adverse effects.
IV N-methylacrylamide Ten weeks feeding at 400 ppm was followed by three weeks at 800 ppm. During the next two weeks four rats received seven doses of 100 mg/kg. One rat became very weak and was killed. The remaining three received 10 further doses of 50 mg/kg without deterioration followed by a further 11 doses of 100 mg/kg during the next three weeks. At the end of this period two of the three had definite weakness like mild acrylamide poisoning.
V N-hydroxymethylacrylamide Experiment 1 Six male rats received seven doses of 100 mg/kg in 12 days, and on day 23 and 24 a dose of 200 mg/kg. They showed fine tremors and were generally affected but did not develop the gross clinical picture of weakness. Killed on day 37 none showed the typical bladder changes from chronic urinary retention seen in many rats poisoned with acrylamide.
Experiment 2 Six male rats fed a diet containing 400 ppm for 14 weeks followed by seven weeks at 800 ppm and then six weeks at 1600 ppm. At the end of this 27-week period of feeding the rats all had definite weakness which recovered somewhat during the three months following their return to a normal diet. These findings are discussed below.
VI NN-diethylacrylamide Six male rats were fed a diet containing 400 ppm for 10 weeks followed by three weeks at 800 ppm and during the next two weeks seven doses of 100 mg/kg. There were no adverse effects.
VII 2-Methylacrylamide Six male rats were given 10 successive doses of 50 mg/kg over 11 days followed by 10 doses of 100 mg/kg over the next 14 days. There were no adverse effects.
VIII Crotonamide
Six male rats were fed a diet containing 400 ppm for nine weeks followed by 800 ppm for the next five weeks. Four of the rats then received seven doses of 100 mg/kg over the next nine days. There were no adverse effects.
IX Senecioic acid amide Six male rats were fed a diet containing 400 ppm for 10 weeks followed by 800 ppm for three weeks and then four of the rats were given seven doses of 100 mg/kg during the next nine days. There were no adverse effects. X Allylacetamide (pent-4 :5-enoic acid amide) Six female rats were given seven doses of 100 mg/kg over eight days followed by 10 doses of 200 mg/kg over the next 14 days. There were no adverse effects.
Discussion
These experiments indicate that among a series of closely related compounds acrylamide is unique in Observations on the effects on rats of compounds related to acrylamide 149 its ability to produce acute and chronic toxic effects in rats associated with injury to the nervous system. In the experiments described above, N-hydroxymethylacrylamide from a commercial source was used and appeared to have a very weak activity compared to that of acrylamide. In later work on the mechanism of action of acrylamide, Hashimoto and Aldridge (1970) made further studies with N-hydroxymethylacrylamide but, as a first step, purified the commercial product which was found to contain some acrylamide. Difficulties of separation made it impossible to determine the exact degree of contamination, but it was undoubtedly quite low. However, Hashimoto and Aldridge (1970) went on to show that rats which were exposed to pure N-hydroxymethylacrylamide in doses that did not produce evidence of neurological damage were more sensitive to the neurotoxic effects of acrylamide. It is probable, therefore, that the neurotoxic effects of the very large doses of commercial N-hydroxymethylacrylamide used in these experiments was due to the presence of acrylamide. N-methylacrylamide also had some slight effect in large doses.The purity of this compound was not checked. It is unlikely that N-demethylation occurs since the intermediate product would be N-hydroxymethylacrylamide which is not neurotoxic.
